All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

110

Reset

110 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • JPI-547Phase 23 trials

    Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer

  • RC88The RC88Phase 23 trials

    RemeGen Co., Ltd. · Solid Tumor, Advanced Solid Tumours, Primary Peritoneal Cancer

  • REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • TulmimetostatDZR123, Tulmimetostat DL1Phase 23 trials

    Novartis · Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Advanced Solid Tumor

  • AVZO-021Phase 22 trials

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials

    Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive

  • CYH33Phase 22 trials

    Haihe Biopharma Co., Ltd. · PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM), Ovarian Cancer

  • Beijing Biotech · Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • GI-102Phase 22 trials

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)

  • LorigerlimabMGD019Phase 22 trials

    MacroGenics · Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma

  • M1774TuvusertibPhase 22 trials

    EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer

  • PF-07104091ovarian, SCLCPhase 22 trials

    Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer

  • RadspherinPhase 22 trials

    Oncoinvent Solutions AS · Peritoneal Carcinomatosis, Ovarian Cancer, Peritoneal Carcinoma

  • rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials

    Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer

  • SYS6041Phase 22 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Ovarian Cancer, Recurrent Ovarian Cancer, Advanced Solid Tumors

  • vudalimabPhase 22 trials

    Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • ACE-86225106Phase 21 trial

    Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation

  • AMXI-5001Phase 21 trial

    AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • AST-201Phase 21 trial

    Aston Sci. Inc. · Advanced Ovarian Cancer

  • ATX-295Phase 21 trial

    Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • AZD8205Phase 21 trial

    AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer

  • AZD8421Phase 21 trial

    AstraZeneca · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

  • B013Phase 21 trial

    Shanghai Jiaolian Drug Research and Development Co., Ltd · Platinum-resistant Recurrent Ovarian Cancer

  • BI-1808Phase 21 trial

    BioInvent International AB · Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma

  • BMX-001Phase 21 trial

    BioMimetix JV, LLC · Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm

  • CBX-12Phase 21 trial

    Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma

  • COM701Phase 21 trial

    Compugen Ltd · Ovarian Cancer, Ovarian Cancer Recurrent

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • CYT-0851Phase 21 trial

    Cyteir Therapeutics, Inc. · Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma

  • DAT-2645Phase 21 trial

    Danatlas Pharmaceuticals Co., Ltd · Advanced or Metastatic Ovarian Cancer

  • DC05F01Phase 21 trial

    Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial

    NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer

  • ETX-19477Phase 21 trial

    858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • gavo-celPhase 21 trial

    TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • IBI305Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer

  • IMGN151Phase 21 trial

    AbbVie · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer

  • INV-6452Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • INX-315Phase 21 trial

    Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor

  • KAND567FractalkinePhase 21 trial

    Novakand Pharma AB · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

NewerPage 2 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.